185 related articles for article (PubMed ID: 19816657)
1. Mechanisms for the activity of heterocyclic cyclohexanone curcumin derivatives in estrogen receptor negative human breast cancer cell lines.
Somers-Edgar TJ; Taurin S; Larsen L; Chandramouli A; Nelson MA; Rosengren RJ
Invest New Drugs; 2011 Feb; 29(1):87-97. PubMed ID: 19816657
[TBL] [Abstract][Full Text] [Related]
2. A novel curcumin derivative increases the cytotoxicity of raloxifene in estrogen receptor-negative breast cancer cell lines.
Taurin S; Nimick M; Larsen L; Rosengren RJ
Int J Oncol; 2016 Jan; 48(1):385-98. PubMed ID: 26648459
[TBL] [Abstract][Full Text] [Related]
3. RL71, a second-generation curcumin analog, induces apoptosis and downregulates Akt in ER-negative breast cancer cells.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Sep; 41(3):1119-27. PubMed ID: 22710975
[TBL] [Abstract][Full Text] [Related]
4. Heterocyclic cyclohexanone monocarbonyl analogs of curcumin can inhibit the activity of ATP-binding cassette transporters in cancer multidrug resistance.
Revalde JL; Li Y; Hawkins BC; Rosengren RJ; Paxton JW
Biochem Pharmacol; 2015 Feb; 93(3):305-17. PubMed ID: 25543853
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin.
Yadav B; Taurin S; Rosengren RJ; Schumacher M; Diederich M; Somers-Edgar TJ; Larsen L
Bioorg Med Chem; 2010 Sep; 18(18):6701-7. PubMed ID: 20728364
[TBL] [Abstract][Full Text] [Related]
6. RL66 a second-generation curcumin analog has potent in vivo and in vitro anticancer activity in ER‑negative breast cancer models.
Yadav B; Taurin S; Larsen L; Rosengren RJ
Int J Oncol; 2012 Nov; 41(5):1723-32. PubMed ID: 22971638
[TBL] [Abstract][Full Text] [Related]
7. Identification of cyclohexanone derivatives that act as catalytic inhibitors of topoisomerase I: effects on tamoxifen-resistant MCF-7 cancer cells.
Leung E; Rewcastle GW; Joseph WR; Rosengren RJ; Larsen L; Baguley BC
Invest New Drugs; 2012 Dec; 30(6):2103-12. PubMed ID: 22105790
[TBL] [Abstract][Full Text] [Related]
8. Induction of Apoptosis and Regulation of MicroRNA Expression by (2
Yeap SK; Mohd Ali N; Akhtar MN; Razak NA; Chong ZX; Ho WY; Boo L; Zareen S; Kurniawan TA; Avtar R; Ng SYL; Ong AHK; Alitheen NB
Molecules; 2021 Feb; 26(5):. PubMed ID: 33652854
[TBL] [Abstract][Full Text] [Related]
9. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
10. Potent anti-cancer effects of less polar Curcumin analogues on gastric adenocarcinoma and esophageal squamous cell carcinoma cells.
Alibeiki F; Jafari N; Karimi M; Peeri Dogaheh H
Sci Rep; 2017 May; 7(1):2559. PubMed ID: 28566729
[TBL] [Abstract][Full Text] [Related]
11. Relevance of mitogen activated protein kinase (MAPK) and phosphotidylinositol-3-kinase/protein kinase B (PI3K/PKB) pathways to induction of apoptosis by curcumin in breast cells.
Squires MS; Hudson EA; Howells L; Sale S; Houghton CE; Jones JL; Fox LH; Dickens M; Prigent SA; Manson MM
Biochem Pharmacol; 2003 Feb; 65(3):361-76. PubMed ID: 12527329
[TBL] [Abstract][Full Text] [Related]
12. Anticancer potential of novel curcumin analogs towards castrate-resistant prostate cancer.
Chen S; Nimick M; Cridge AG; Hawkins BC; Rosengren RJ
Int J Oncol; 2018 Feb; 52(2):579-588. PubMed ID: 29207190
[TBL] [Abstract][Full Text] [Related]
13. Curcumin inhibits proliferation and migration by increasing the Bax to Bcl-2 ratio and decreasing NF-kappaBp65 expression in breast cancer MDA-MB-231 cells.
Chiu TL; Su CC
Int J Mol Med; 2009 Apr; 23(4):469-75. PubMed ID: 19288022
[TBL] [Abstract][Full Text] [Related]
14. The Molecular Targets and Anti-Invasive Effects of 2,6-bis-(4-hydroxyl-3methoxybenzylidine) cyclohexanone or BHMC in MDA-MB-231 Human Breast Cancer Cells.
Harun SNA; Israf DA; Tham CL; Lam KW; Cheema MS; Md Hashim NF
Molecules; 2018 Apr; 23(4):. PubMed ID: 29642589
[TBL] [Abstract][Full Text] [Related]
15. Potent growth suppressive activity of curcumin in human breast cancer cells: Modulation of Wnt/beta-catenin signaling.
Prasad CP; Rath G; Mathur S; Bhatnagar D; Ralhan R
Chem Biol Interact; 2009 Oct; 181(2):263-71. PubMed ID: 19573523
[TBL] [Abstract][Full Text] [Related]
16. New bis(hydroxymethyl) alkanoate curcuminoid derivatives exhibit activity against triple-negative breast cancer in vitro and in vivo.
Hsieh MT; Chang LC; Hung HY; Lin HY; Shih MH; Tsai CH; Kuo SC; Lee KH
Eur J Med Chem; 2017 May; 131():141-151. PubMed ID: 28319780
[TBL] [Abstract][Full Text] [Related]
17. ST09, A Novel Curcumin Derivative, Blocks Cell Migration by Inhibiting Matrix Metalloproteases in Breast Cancer Cells and Inhibits Tumor Progression in EAC Mouse Tumor Models.
Nirgude S; Mahadeva R; Koroth J; Kumar S; Kumar KSS; Gopalakrishnan V; S Karki SS; Choudhary B
Molecules; 2020 Sep; 25(19):. PubMed ID: 33008036
[TBL] [Abstract][Full Text] [Related]
18. The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells.
Li JP; Yang YX; Liu QL; Pan ST; He ZX; Zhang X; Yang T; Chen XW; Wang D; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1627-52. PubMed ID: 25834401
[TBL] [Abstract][Full Text] [Related]
19. Cyclohexanone curcumin analogs inhibit the progression of castration-resistant prostate cancer in vitro and in vivo.
Mapoung S; Suzuki S; Fuji S; Naiki-Ito A; Kato H; Yodkeeree S; Ovatlarnporn C; Takahashi S; Limtrakul Dejkriengkraikul P
Cancer Sci; 2019 Feb; 110(2):596-607. PubMed ID: 30499149
[TBL] [Abstract][Full Text] [Related]
20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
